Peer-reviewedCC BYMedical sciences (Basel, Switzerland)
Cutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review
4 affiliations
- 1Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, , Toronto, ON M5S 1A8, Canada;
- 2Independent Researcher, London, ON N5X 2P1, Canada
- 3Dermatology Division, School of Medical Science, , Campinas 13083-894, Brazil;
- 4Department of Dermatology, The Permanente Medical Group, Vallejo, CA 94589, USA;
Related
- Musculoskeletal Adverse Event Signals Associated With Semaglutide, Liraglutide, and Tirzepatide in the US FDA Adverse Event Reporting System.
- Psychiatric and psychological adverse effects associated with dulaglutide, semaglutide, and liraglutide: A vigibase study
- Indication-specific adverse event profiles of semaglutide and liraglutide: a FAERS disproportionality analysis
- Cutaneous Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Semaglutide vs. liraglutide and incidence of diabetes and cardiovascular disease: A target trial emulation using real‐world data
BibTeX
@article{gupta2026cutaneous,
title = {{Cutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review}},
author = {Aditya K. Gupta and Elizabeth M. Teasell and Renata F. Magalhães and Paradi Mirmirani and Vincent Piguet},
journal = {Medical sciences (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13707166},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review
AU - Aditya K. Gupta
AU - Elizabeth M. Teasell
AU - Renata F. Magalhães
AU - Paradi Mirmirani
AU - Vincent Piguet
PY - 2026
DA - 2026/10/01
JO - Medical sciences (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13707166
SN - 2076-3271
ER -